Home > Insider Trading > Filing (0001179110-13-004337)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884629	Actavis Inc.	ACT	Pharmaceutical Preparations (2834)	953872914

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1337012	Iii Albert Paonessa	Morris Corporate Center Iii 400 Interpace Parkway Parsippany NJ 07054	President Of Anda, Inc.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0033	Disposition	2013-03-02	2,028	$85.54	39,495	No	4	F	Direct
Common Stock, Par Value $0.0033	Disposition	2013-03-05	4,413	$86.05	35,082	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.02 to $86.14, inclusive. The reporting person undertakes to provide to Actavis, Inc., any security holder of Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc., as amended.